Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionPSCH - Invesco S&P SmallCap Health Care ETF
Latest Disclosed Ownership96,176 shares
Latest Disclosed Value $ 2,219,742
PSCH - Invesco S&P SmallCap Health Care ETF reports 1.62% decrease in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On April 28, 2026 - PSCH - Invesco S&P SmallCap Health Care ETF filed a NPORT-P form disclosing ownership of 96,176 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $2,219,742 USD as of February 28, 2026. The entity filed a previous NPORT-P on January 28, 2026 disclosing 97,756 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of -1.62% during the quarter. The current value of the position is $3,028,582 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 96,176 -1,580 -1.62 2,220 -3.02 1.5882
2026-01-28 2025-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 97,756 -14,764 -13.12 2,288 -1.21 1.4787
2025-10-28 2025-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 112,520 -5,017 -4.27 2,317 -21.04 1.6144
2025-07-28 2025-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 117,537 -8,634 -6.84 2,934 1.56 1.9993
2025-04-25 2025-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 126,171 -8,168 -6.08 2,888 -2.56 1.6605
2025-01-28 2024-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 134,339 -29,212 -17.86 2,965 -10.48 1.4998
2024-10-28 2024-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 163,551 -28,778 -14.96 3,312 6.50 1.6148
2024-07-29 2024-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 192,329 -7,816 -3.91 3,110 -3.09 1.5261
2024-04-25 2024-02-29 NP Catalyst Pharmaceuticals EC US14888U1016 200,145 -5,183 -2.52 3,208 8.31 1.4707
2024-01-29 2023-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 205,328 -34,527 -14.39 2,963 -12.03 1.4433
2023-10-30 2023-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 239,855 -34,878 -12.70 3,368 6.11 1.3142
2023-07-28 2023-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 274,733 -34,199 -11.07 3,173 -32.69 1.1276
2023-05-01 2023-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 308,932 -2,546 -0.82 4,714 -9.75 1.4749
2023-01-30 2022-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 311,478 311,478 5,223 1.5695
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.